ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,913Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 103

$586K Total Retail Price of All Prescriptions

Rank: 16 out of 103

672 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 672 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 672 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 12,553 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 682 682 1 4
FUROSEMIDE 528 514 2 6
OMEPRAZOLE 473 456 3 7
CITALOPRAM HBR 359 359 4 10
POTASSIUM CHLORIDE 354 344 5 12
AMLODIPINE BESYLATE 353 353 6 5
SIMVASTATIN 349 338 7 1
LISINOPRIL 335 322 8 2
WARFARIN SODIUM 329 329 9 9
POLYETHYLENE GLYCOL 3350 302 302 10 32
HYDROCODONE-ACETAMINOPHEN 282 269 S3 11 3
DONEPEZIL HCL 219 219 12 11
NAMENDA 213 213 13 16
GABAPENTIN 211 199 14 13
PREDNISONE 191 189 15 38
METOPROLOL TARTRATE 189 175 16 8
SERTRALINE HCL 177 177 17 18
METOPROLOL SUCCINATE 172 172 18 17
ALENDRONATE SODIUM 150 150 19 25
MIRTAZAPINE 149 148 20 24
CARVEDILOL 144 132 21 22
ATENOLOL 141 140 22 19
TRAMADOL HCL 134 129 23 20
QUETIAPINE FUMARATE 115 115 24 46
CARBIDOPA-LEVODOPA 110 110 25 60
CLOPIDOGREL 106 99 26 28
LIDOCAINE HCL 106 105 26 185
RAMIPRIL 105 105 28 102
KLOR-CON M20 104 104 29 73
TRAZODONE HCL 98 98 30 39
GLIPIZIDE 96 95 31 40
ISOSORBIDE MONONITRATE ER 95 86 32 26
CYMBALTA 94 91 33 56
LOSARTAN POTASSIUM 93 93 34 23
LOVASTATIN 90 90 35 55
FENTANYL 88 88 S2 36 48
JANTOVEN 87 80 37 96
LANTUS 84 84 38 29
ZOLPIDEM TARTRATE 80 77 39 35
HYDROCHLOROTHIAZIDE 80 80 39 15
NYSTATIN 80 79 39 84
TAMSULOSIN HCL 77 77 42 30
DIGOXIN 76 76 43 49
PLAVIX 74 69 44 44
RANITIDINE HCL 73 73 45 31
VENLAFAXINE HCL ER 73 61 45 90
ESCITALOPRAM OXALATE 72 72 47 50
ADVAIR DISKUS 66 54 48 43
METHADONE HCL 66 66 S2 48 106
HYDRALAZINE HCL 65 64 50 34
ATORVASTATIN CALCIUM 64 62 51 21
METFORMIN HCL 62 62 52 14
SPIRONOLACTONE 58 57 53 71
DILTIAZEM 24HR CD 56 56 54 118
DIVALPROEX SODIUM 56 56 54 45
VENLAFAXINE HCL 52 52 56 186
SPIRIVA 52 47 56 51
DILTIAZEM 24HR ER 51 51 58 107
DIOVAN 51 51 58 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.